Author

Meaghan Fowle

Institution: Curis (United States)

Observed institution: Curis (United States)

OpenAlex ID: A5093396776

Preliminary Safety and Efficacy of Emavusertib (CA-4948) in Combination with Ibrutinib in Relapsed/Refractory Primary Central Nervous System Lymphoma Patients with Prior Exposure to BTK Inhibitor

2024 · Grzegorz S. Nowakowski, Anna Paulina Dabrowska-Iwanicka, et al. · Blood · 5

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

2023 · Christian Grommes, Grzegorz S. Nowakowski, et al. · Blood

Works count: 2

Citation count: 5

H-index: 1

I10-index: